## **Core Concept**
The question tests understanding of the mechanism of action of various cardiovascular drugs, specifically those that act on calcium channels. Calcium channel blockers (CCBs) are a class of drugs that inhibit the influx of calcium ions into cardiac and smooth muscle cells, leading to vasodilation and reduced myocardial contractility.

## **Why the Correct Answer is Right**
acts by stimulating the release of calcium from the sarcoplasmic reticulum, thereby increasing the intracellular concentration of calcium ions. This mechanism is different from that of calcium channel blockers, which directly inhibit the influx of calcium ions through L-type calcium channels in the heart and blood vessels.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is a calcium channel blocker that inhibits L-type calcium channels, reducing calcium influx into cardiac and smooth muscle cells.
* **Option B:** is also a calcium channel blocker with a similar mechanism of action to , inhibiting calcium influx.
* **Option D:** is a calcium channel blocker that acts on L-type calcium channels, similar to and .

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that calcium channel blockers are classified into two main types based on their primary site of action: dihydropyridines (e.g., , ) act mainly on vascular smooth muscle, while non-dihydropyridines (e.g., , ) act on the heart and vascular smooth muscle.

## **Correct Answer:** .